Searchable abstracts of presentations at key conferences in endocrinology

ea0022p314 | Diabetes | ECE2010

Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes

Kristensen Peter Lommer , Pedersen-Bjergaard Ulrik , Olsen Niels Vidiendal , Schalkwijk Caper , Thorsteinsson Birger

Aims/hypothesis: Circulating erythropoietin (EPO) and vascular endothelial growth factor (VEGF) increase during hypoglycaemia and may represent a protective hormonal counter-regulatory response. We tested the hypothesis that low levels of EPO and VEGF are associated with a higher frequency of severe hypoglycaemia in a cohort of patients with type 1 diabetes.Methods: Two hundred and nineteen patients with type 1 diabetes (41% females, age 46±13 years...